Nexalin Technology (NXL) said the US Patent and Trademark Office issued a patent expected to provide core intellectual property protection for its dynamic frequency stimulation method through 2042, strengthening its competitive position in deep-brain neurostimulation for depression and insomnia.
The patent covers methods including transcranial alternating current stimulation, the company said Thursday in a statement.
Price: $0.50, Change: $-0.03, Percent Change: -5.41%
Rollins' (ROL) organic growth in Q2 is likely to accelerate along with incremental margins despite near-term pressures from elevated fuel costs, RBC Capital Markets analysts said in a note emailed Thursday.Analysts said that Google search trends for "Pest Control" remain elevated compared with historical levels, with unique visits to pest control websites up 23% in April from a year earlier.RBC said that warmer and drier weather conditions in March and April have also likely increased pest activity, further supporting industry tailwinds.For Rollins, analysts expect margin expansion into the high-20% range in Q2, driven by accelerating organic growth, normalization of insurance and claims expenses, and operating leverage from higher volumes.RBC maintained its outperform rating and a $67 price target on the stock.Price: $46.37, Change: $+0.58, Percent Change: +1.27%
CrowdStrike's (CRWD) cyber-AI strategy continues to play out, with expansive pipeline for its cyber-AI product portfolio driving bookings pipeline, Wedbush Securities said in a Thursday note.The company reported Q1 results featuring slight beats across the board while slightly raising its FY27 guidance, the note said.CrowdStrike was the only company to secure both Anthropic's and OpenAI's cyber defense projects, pointing to the rising need for cybersecurity ecosystems for AI deployments, it said."We continue to believe that CRWD's position as the gold standard of cybersecurity remains firmly unchanged," the report said, pointing to its Falcon platform.Wedbush kept its outperform rating while raising its price target to $720 from $700 to reflect significant momentum for itsplatform approach.Price: $694.10, Change: $-53.51, Percent Change: -7.16%
Broadcom (AVGO) delivered "very strong" fiscal Q2 results, and its outlook is likely to remain "conservative" despite continued strength in artificial intelligence-driven growth, Morgan Stanley said in a note Thursday.The bank said the company's AI business grew 30% in April and accelerated to 200% year-over-year growth in July, representing roughly 40% sequential growth. Guidance for about $56 billion of AI revenue this year and "well above" $100 billion next year is impressive and broadly in line with consensus expectations."Further, we think there is upside - the doubling half-over-half implies upside to H2, and the current 'growth trajectory continues' points to higher growth," the firm said, adding that, during the group callback, Broadcom indicated that its outlook for 2027 has improved. However, management declined to provide more specific guidance. The company also suggested that strong growth could extend well into 2028.The bank said that for Broadcom's fiscal 2026, it now forecasts revenue of $106 billion, non-GAAP gross margin of 74.8%, and earnings per share of $11.59, compared with its prior estimates of $105 billion, 74.9%, and $11.42. For fiscal 2027, it projects revenue of $167 billion, non-GAAP gross margin of 70.8%, and EPS of $18.28, versus its prior estimates of $168 billion, 71%, and $17.97.Morgan Stanley raised its price target on Broadcom from $485 to $502 while keeping its overweight rating.Shares of the company fell nearly 15% in the session.Price: $408.52, Change: $-70.71, Percent Change: -14.75%